In contrast to individuals without a history of cancer, hospital death rates in persons with a history of cancer do not appear to have decreased over time, according to a large prospective analysis of COVID-19 outcomes in adults with a history of cancer.
The findings of the Clinical Characterization Protocol (CCP) CANCER-UK study, led by Liverpool researchers in collaboration with Edinburgh colleagues, are based on anonymized data from more than 195,000 people hospitalized in the UK, including more than 20,000 people with a history of cancer, defined as either being on active cancer treatment or have had a previous diagnosis of cancer.
COVID Death Rates In Cancer Patients Are Not As Low Without A History Of Cancer
During the pandemic, people who succumbed to infection got severe medical issues. Hence, experts surveyed to know the medical condition of those who suffer from cancer of any type and those who do not have any such ailment. They found situations in both categories almost similar.
Although there has been a consistent drop in mortality rates for persons without a history of cancer since January 2020, the same is not true for people with a history of cancer, according to data given at this year’s European Society of Medical Oncology (ESMO) conference.
Furthermore, between February 2021 and July 2021, the mortality disparity between persons with a history of cancer and those without a history of cancer expanded.
The causes behind these findings are still unknown. More data is being collected, and a study is being done to figure out why, unlike those without a history of cancer, mortality among persons with a history of cancer who are hospitalized with COVID-19 has not altered during the duration of the epidemic.
“These statistics demonstrate clear trends in mortality,” stated co-leader Professor Carlo Palmieri of The Clatter bridge Cancer Centre and the University of Liverpool. Since January 2020, the mortality rate for hospitalized patients without a history of cancer has reduced. People with a history of cancer, on the other hand, did not witness a decrease in mortality with time, with actual maxima noted over the final year.
Most notably, whereas COVID-19-related mortality in persons without a history of cancer has decreased dramatically since January 2021, COVID-19-related deaths in people with a history of cancer have increased.
“We don’t know why we don’t see an improvement in the mortality of COVID-19 kids who are hospitalized, and we’re working hard to figure out why.”
Dr. Lance Turtle of Liverpool University Hospitals and the University of Liverpool said: “People with weakened immune systems, such as those undergoing cancer treatment, are likely to be more vulnerable to COVID in the future. It’s critical that as many people as possible get vaccinated and that we know who is most vulnerable.”
In contrast to individuals without a history of cancer, hospital death rates in persons with a history of cancer do not appear to have decreased over time, according to a large prospective analysis of COVID-19 outcomes in adults with a history of cancer.
The findings of the Clinical Characterization Protocol (CCP) CANCER-UK study, led by Liverpool researchers in collaboration with Edinburgh colleagues, are based on anonymized data from more than 195,000 people hospitalized in the UK, including more than 20,000 people with a history of cancer, defined as either being on active cancer treatment or have had a previous diagnosis of cancer.
The causes behind these findings are still unknown. More data is being collected, and a study is being done to figure out why, unlike those without a history of cancer, mortality among persons with a history of cancer who are hospitalized with COVID-19 has not altered during the duration of the epidemic.
